Presentación simultánea de trastornos del espectro autista y de síntomas de déficit de atención e hiperactividad

• German Eduardo Velez Florez ; María Camila Vélez Flórez ^[2] ; Roberto Chaskel ^[1]
  1. [1] Universidad El Bosque

     Universidad El Bosque

     Colombia

     
  2. [2] Department of Radiology, The Children's Hospital of Philadelphia, Pensilvania
• Localización: Revista de Psicopatología y salud mental del niño y del adolescente, ISSN 1695-8691, Nº. 33, 2019, págs. 23-33
• Idioma: español
• Texto completo no disponible (Saber más ...)
• Resumen

  • Los trastornos del espectro autista (TEA) y el trastorno por déficit de atención e hiperactividad (TDAH) son un reto diagnóstico y terapéutico en su presentación simultánea. Existen síntomas comunes con orígenes diversos que interactúan para contribuir en esta presentación. Es indispensable abordar interdisciplinariamente estos casos y adaptar las aproximaciones terapéuticas con el propósito de lograr resultados favorables en su funcionalidad y cada uno de sus síntomas comórbidos.

• Referencias bibliográficas
  • Aman, M. G., Farmer, C. A., Hollway, J. y Arnold, L. E. (2008). Treatment of inattention, overac­tivity, and impulsiveness in autism spectrum...
  • American Psychiatric Association (APA) (2013). Diagnostic and statistical manual of mental disorders (DSM-5). Arlington: Ameri­can Psychiatric...
  • American Psychiatry Association (APA) (1994). Diagnostic and statistical manual of mental di­sorders (DSM-IV). American Psychiatry Asso­ciation,...
  • Anderson, D. K., Liang, J. W. y Lord, C. (2014). Predicting young adult outcome among more and less cognitively able individuals with au­tism...
  • Antshel, K. M., Polacek, C., McMahon, M., Dygert, K., Spenceley, L., Dygert, L., … y Faisal, F. (2011). Comorbid ADHD and anxiety affect social...
  • Antshel, K. M., Zhang-James, Y., Wagner, K. E., Ledesma, A. y Faraone, S. V. (2016). An up­date on the comorbidity of ADHD and ASD: A focus...
  • Barbaresi, W., Katusic, S., Colligan, R., Wea­ver, A., Pankratz, V., Mrazek, D. y Jacobsen, S. (2004). How common is attention-deficit/hyperactivity...
  • Baxter, A. J., Brugha, T. S., Erskine, H. E., Scheu­rer, R. W., Vos, T. y Scott, J. G. (2015). The epidemiology and global burden of autism...
  • Blumberg, S. J., Bramlett, M. D., Kogan, M. D., Schieve, L. A., Jones, J. R. y Lu, M. C. (2013). Changes in prevalence of parent-reported...
  • Campbell, M., Armenteros, J. L., Malone, R. P., Adams, P. B., Eisenberg, Z. W. y Overall, J. E. (1997). Neuroleptic-related dyskinesias in...
  • Carrascosa-Romero, M. C. y De Cabo-De La Vega, C. (2015). The comorbidity of ADHD and autism spectrum disorders (ASDs) in community preschoolers....
  • Carbone, P. S., Farley, M. y Davis, T. (2010). Pri­mary care for children with autism. Am Fam Physician, 81(4), 453-60.
  • Ceponiene, R., Lepisto, T., Shestakova, A., Van­hala, R., Alku, P., Naatanen, R. y Yaguchi, K. (2003). Speech-sound-selective auditory im­pairment...
  • Ching, H. y Pringsheim, T. (2012). Aripiprazo­le for autism spectrum disorders (ASD). Co­chrane Database Syst Rev, 5.
  • Christensen, D., Baio, J., Braun, K., Bilder, D., Charles, J. y Constantino, J. et al. (2016). Pre­valence and Characteristics of Autism Spec­trum...
  • Cuthbert, B. N. y Insel, T. R. (2013). Toward the future of psychiatric diagnosis: the seven pi­llars of RDoC. BMC medicine, 11(1), 126.
  • Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D. y Blumberg, S. J. (2018). Prevalence of parent-reported ADHD...
  • Davis, N. O. y Kollins, S. H. (2012). Treatment for co-occurring attention deficit/hyperacti­vity disorder and autism spectrum disorder. Neurotherapeutics,...
  • Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A. y Veenstra-VanderWeele, J. (2012). Medications for adolescents and young...
  • DuPaul, G. J., Gormley, M.J. y Laracy, S. D. (2014). School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr...
  • Fayyad, J., De Graaf, R., Kessler, R., Alonso, J., Angermeyer, M. y Demyttenaere, K. et al. (2007). Cross-national prevalence and corre­lates...
  • Fombonne, E. (2009). Epidemiology of Perva­sive Developmental Disorders. Pediatric Re­search, 65(6), 591-598.
  • Food and Drug Administration (FDA) (2016). Aripiprazole (Abilify, Abilify Maintena, Arista­da): Drug Safety Communication – FDA Warns About...
  • Food and Drug Administration (FDA) (2014). Abilify (aripiprazole), approved product in­formation. EEUU: FDA. Recuperado el 7 de mayo de 2017...
  • Frances, A. J. y Widiger, T. (2012). Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future. Annual review...
  • Fung, L. K., Mahajan, R., Nozzolillo, A., Bernal, P., Krasner, A., Jo, B., … y Hardan, A. Y. (2016). Pharmacologic treatment of severe irritabili­ty...
  • Gadow, K., DeVincent, C., Pomeroy, J. y Azi­zian, A. (2004). Psychiatric Symptoms in Preschool Children with PDD and Clinic and Comparison...
  • Gadow, K., Devincent, C., Pomeroy, J. y Azizian, A. (2005). Comparison of DSM-IV symptoms in elementary school-age children with PDD versus...
  • Geller, D., Donnelly, C., Lopez, F., Rubin, R., Newcorn, J., Sutton, V., … y Sumner, C. (2007). Atomoxetine treatment for pediatric patients...
  • Ghanizadeh, A. (2013). Atomoxetine for trea­ting ADHD symptoms in autism: a systematic review. Journal of attention disorders, 17(8), 635-640
  • Golubchik, P., Sever, J. y Weizman, A. (2013). Reboxetine treatment for autistic spectrum disorder of pediatric patients with depres­sive...
  • Harfterkamp, M., van de Loo-Neus, G., Min­deraa, R. B., van der Gaag, R. J., Escobar, R., Schacht, A., … y Hoekstra, P. J. (2012). A randomized...
  • Harfterkamp, M., van der Meer, D., van der Loo-Neus, G., Buitelaar, J. K., Minderaa, R. B. y Hoekstra, P. J. (2015). No evidence for predic­tors...
  • Hollander, E., Dolgoff-Kaspar, R., Cartwright, C., Rawitt, R. y Novotny, S. (2001). An open trial of divalproex sodium in autism spectrum...
  • Hollander, E., Wasserman, S., Swanson, E. N., Chaplin, W., Schapiro, M. L., Zagursky, K. y Novotny, S. (2006). A Double-Blind Placebo-Controlled...
  • Hollander, E., Soorya, L., Wasserman, S., Es­posito, K., Chaplin, W. y Anagnostou, E. (2006). Divalproex sodium vs. placebo in the treatment...
  • Huang, A., Seshadri, K., Matthews, T. A. y Ost­feld, B. M. (2013). Parental perspectives on use, benefits, and physician knowledge of complementary...
  • Huffman, L. C., Sutcliffe, T. L., Tanner, I. S. y Feld­man, H. M. (2011). Management of symptoms in children with autism spectrum disorders:...
  • Joshi, G., Faraone, S. V., Wozniak, J., Tarko, L., Fried, R., Galdo, M., … y Biederman, J. (2017). Symptom profile of ADHD in youth with high-functioning...
  • Kodish, I., Rockhill, C., Ryan, S. y Varley, C. (2011). Pharmacotherapy for anxiety disor­ders in children and adolescents. Pediatric Clinics,...
  • Lawson, R. A., Papadakis, A. A., Higginson, C. I., Barnett, J. E., Wills, M. C., Strang, J. F., … y Kenworthy, L. (2015). Everyday executi­ve...
  • Leskovec, T. J., Rowles, B. M. y Findling, R. L. (2008). Pharmacological treatment options for autism spectrum disorders in children and adolescents....
  • Lim, L., Chantiluke, K., Cubillo, A. I., Smith, A. B., Simmons, A., Mehta, M. A. y Rubia, K. (2015). Disorder-specific grey matter deficits...
  • Liptak, G. S., Orlando, M. S., Yingling, J. T., Theu­rer-Kaufman, K. L., Malay, D. P., Tompkins, L. A. y Flynn, J. R. (2006). Satisfaction...
  • McGorry, P. D., Purcell, R., Hickie, I. B., Yung, A. R., Pantelis, C. y Jackson, H. J. (2007). Clini­cal staging: a heuristic model for psychiatry...
  • McPheeters, M. L., Warren, Z., Sathe, N., Bruzek, J. L., Krishnaswami, S., Jerome, R. N. y Veens­tra-VanderWeele, J. (2011). A systematic...
  • Marquand, A. F., De Simoni, S., O’daly, O. G., Wi­lliams, S. C., Mourão-Miranda, J. y Mehta, M. A. (2011). Pattern classification of working...
  • Masi, A., DeMayo, M. M., Glozier, N. y Guastella, A. J. (2017). An overview of autism spectrum disorder, heterogeneity and treatment op­tions....
  • McCracken, J. T., McGough, J., Shah, B., Cro­nin, P., Hong, D., Aman, M. G., … y McDougle, C. J. (2002). Risperidone in children with autism...
  • McVoy, M. y Findling, R. (2009). Child and ado­lescent psychopharmacology update. Psychia­tric Clinics of North America, 32(1), 111-133.
  • Murray, M. (2010). Attention-deficit/Hyperacti­vity Disorder in the Context of Autism Spec­trum Disorders. Current Psychiatry Reports, 12(5),...
  • National Institute for Health and Care Excellen­ce (NICE) (2017). Autism. Manchester: NICE. Recuperado el 12 de diciembre de 2017 de https://www.nice.org.uk.ez.urosario.edu.co/guidance/conditions-and-diseases/mental-health-and-behavioural-conditions/autism
  • Oerlemans, A. M., Van der Meer, J. M., Van Stei­jn, D. J., De Ruiter, S. W., De Bruijn, Y. G., De Sonneville, L. M., … y Rommelse, N. N. (2014)....
  • Oerlemans, A. M., Burmanje, M. J., Franke, B., Buitelaar, J. K., Hartman, C. A. y Rommelse, N. N. (2016). Identifying unique versus sha­red...
  • Papadopoulos, N., Sciberras, E., Hiscock, H., Mulraney, M., McGillivray, J. y Rinehart, N. (2015). The efficacy of a brief behavioral sleep...
  • Pearson, D. A., Santos, C. W., Aman, M. G., Ar­nold, L. E., Casat, C. D., Mansour, R., … y Factor, P. (2013). Effects of extended release...
  • Pelphrey, K. A., Viola, R. J. y McCarthy, G. (2004). When strangers pass: processing of mutual and averted social gaze in the supe­rior temporal...
  • Pennington, B. y Ozonoff, S. (1996). Executi­ve Functions and Developmental Psycho­pathology. Journal Of Child Psychology And Psychiatry,...
  • Reichow, B., Volkmar, F. R. y Bloch, M. H. (2013). Systematic review and meta-analysis of phar­macological treatment of the symptoms of attention-deficit/hyperactivity...
  • Scahill, L., McCracken, J. T., King, B. H., Rockhill, C., Shah, B., Politte, L., … y Page, C. (2015). Ex­tended-release guanfacine for hyperactivity...
  • Shaw, P., Malek, M., Watson, B., Sharp, W., Evans, A. y Greenstein, D. (2012). Develop­ment of cortical surface area and gyrifica­tion in...
  • Smith, T. y S. Ladarola, Evidence Base Upda­te for Autism Spectrum Disorder. J Clin Child Adolesc Psychol, 2015. 44(6): p. 897-922.
  • Stoodley, C. J. y Schmahmann, J. D. (2009). Functional topography in the human cere­bellum: a meta-analysis of neuroimaging stu­dies. Neuroimage,...
  • Sturman, N., Deckx, L. y van Driel, M. L. (2017). Methylphenidate for children and adoles­cents with autism spectrum disorder. The Co­chrane...
  • Subcommittee on Attention-Deficit / Hyperac­tivity Disorder (2011). ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment...
  • Thomas, R., Sanders, S., Doust, J., Beller, E. y Glasziou, P. (2015). Prevalence of attention-deficit/hyperactivity disorder: a systematic...
  • Wentz, E., Nydén, A. y Krevers, B. (2012). De­velopment of an internet-based support and coaching model for adolescents and young adults with...
  • Young, N. y Findling, R. (2015). An update on pharmacotherapy for autism spectrum disor­der in children and adolescents. Current Opi­nion...